Gene Therapy in Cardiovascular Disorder Market Size, Share, Analysis and Forecast to 2030
Gene therapy in cardiovascular disorder market is estimated to be worth US$ 178 million in 2023 and is projected to reach US$ 1,351.3 million by 2030, growing at a CAGR of 21.1% during the forecast period 2024-2030.
This significant growth is driven by factors such as rising prevalence of cardiovascular diseases, increasing investments in gene therapy research and development, and growing...
0 Comments
0 Shares
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)